Synthesis, Characterization, Molecular Docking and in vitro Anticancer Screening of Some Novel Thiophene Derivatives

One of the diseases in the 21(st) century is still cancer and there is significant research being done all over the world to find a medicine that is more effective and has fewer adverse effects. More than 19 million new cases of cancer have been reported by global statistics and an estimated 10 million people have died from it in 2020. We continue to work on the development of new pharmacological entities because we are motivated in the research area. We have created novel thiophene derivatives and have screened them against the U87-MG cell line to see whether they have any anticancer properties. It was observed that the AP-C12 extract showed the highest inhibition in the U87-MG cell line (EC50: 9.1 mu M) which was a very good comparison to Temozolomide (EC50: 61.2 mu M). Similarly, AP-C7 exhibited considerable potency against the U87-MG cell line with EC50 values of 12.3 mu M.